Chemical biology networks
In May 2011 BBSRC, EPSRC, and MRC jointly invested £1.2M in seven networks to improve collaboration between academia and industry at the chemical biology interface.
In addition to the Research Councils' investment, over 20 user organisations, including AstraZeneca, Bayer, Cancer Research UK, GlaxoSmithKline, the NHS, Pfizer, Syngenta and UCB are investing significant resource in seven separate networks.
The networks will collaborate on a range of activities to enable knowledge-sharing and innovative discipline-hopping between academia and users across the breadth of chemical biology research and development.
Chemical biology is the use of chemistry and chemical tools to understand and solve biological problems. It is an area of great economic value as it is an essential component of innovative research in areas such as:
- Drug discovery
The academic collaborators leading the seven networks are:
- Dr Laura Barter (Imperial College London): Agri-Science Chemical Biology Network
- Professor Weng Chan (The University of Nottingham): Cell Control in a Petri Dish (CCPD) Collaborative Network
- Professor Beining Chen (The University of Sheffield): Stem Cells, Prion Proteins and Alzheimer's Diseases: A Prion Chemical Biology Network (PCBNet)
- Professor David Klug (Imperial College London) and Professor Andrew Wilson (University of Leeds): Protein-Protein Interaction Inhibitors: From Design and Synthesis, Through Biophysics to Cell Permeable Inhibitors
- Professor Jason Micklefield (The University of Manchester): Manchester Chemical Biology Network
- Professor Nick Tomkinson (Cardiff University): Alignment of Synthesis, Medicinal Chemistry and Structural Genomics to Accelerate UK Drug Discovery: Network SMS-Drug
- Professors Paul Wyatt and Ian Gilbert (University of Dundee): 3D Libraries Consortium